The Dipeptidyl Peptidase-4 Inhibitors Market is experiencing steady global growth as the prevalence of type 2 diabetes continues to increase across developed and emerging economies. Rising demand for effective oral glucose-lowering therapies, growing adoption of combination treatment regimens, and continuous advancements in pharmaceutical research are supporting market expansion. The...